1. /
  2. Commercialisation /
  3. Vaccines
Commercialisation

Vaccines

The Burnet Vaccine Initiative (BVI) brings together our institute’s leading experts in virology, immunology, parasitology, and vaccine design to develop novel vaccine candidates and strategies for high lasting protection against some of the world’s most devastating pathogens. 

We are ready to talk about opportunities through research collaborations, licensing of technology, and partnerships.

BVI Flyer Cover Thumbnail

Burnet Vaccine Initiative

This flyer contains information about our deep expertise in vaccine development, our range of novel vaccine antigens, and our partners.

BVI flyer [PDF 238 kB]
Betacoronaviruses Flyer Cover Thumbnail

Betacoronaviruses

This flyer contains information about our pan-betacoronavirus vaccine, our platform-agnostic approach, and the benefits of our new technology.

Betacoronaviruses flyer [PDF 344 kB]
On this page